Emergency Medicine
Anaphylaxis Management
Recognition and immediate treatment of anaphylaxis in adults and children, following Resuscitation Council UK / NICE guidelines.
Source: Resuscitation Council UK 2021; NICE CG134
Used in: Anaphylaxis & Allergy
Step 1 of ~7
warning
Recognise Anaphylaxis
Anaphylaxis is likely if ALL THREE of the following:
1. Sudden onset and rapid progression
2. Life-threatening airway / breathing / circulation problems
3. Skin and/or mucosal changes (flushing, urticaria, angioedema)
Note: Anaphylaxis can occur WITHOUT skin changes in up to 20% of cases.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Silicone Gel / Sheeting (Scar Management) · Medical Device / Topical Scar Treatment
- Methylphenidate · CNS Stimulant — Schedule 2 Controlled Drug (ADHD Treatment)
- Lipid Emulsion 20% (Intralipid) · Antidote / Resuscitation
- Insulin (IV Infusion — ICU Glucose Control) · Insulin — ICU Glucose Management
- Sodium Chloride 3% (Hypertonic Saline) · Hypertonic Electrolyte Solution — ICP/Hyponatraemia Management
- Thiamine (IV/IM — Pabrinex) · Vitamin B1 (Thiamine) — deficiency treatment / Wernicke's encephalopathy prevention
Pathways
- Difficult Airway Algorithm (DAS) · DAS 2015; Royal College of Anaesthetists
- Major Haemorrhage Protocol · NICE NG24; UK MHP guidelines
- New-Onset Atrial Fibrillation · ESC 2020 AF Guidelines; NICE NG196
- Hypertensive Emergency · ESC/ESH 2018 Hypertension Guidelines; NICE NG136
- Bradycardia Management · Resuscitation Council UK ABCDE; ESC 2021 Pacing Guidelines
- Ventricular Tachycardia / Fibrillation · Resuscitation Council UK ACLS; ESC 2022 Ventricular Arrhythmia Guidelines
Featured in these MRCEM clinical pathways
A deeper exam-focused version of this pathway is available on our sister siteReviseMRCEM.
MRCEM Primary / Intermediate / OSCE candidates: each pathway includes exam-style questions, RCEM/NICE citations, and FAQ summaries.
Decision support only. Always apply local guidelines and clinical judgement.